Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). (Q34986024)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q43429105)
(Q42169977)
(Q60996888)
(Q6224073)
(Q57687222)
(Q114738369)
(P304) 39-47
(P407) (Q1860)
(P433) 9683
(P478) 374
(P577) Monday, June 8, 2009
(P921) (Q3025883)
(Q2526479)
(P1433) (Q939416)
(P1476) "Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)." (language: en)
(P2093) Wolfgang E Schmidt
Jason H Brett
Lawrence Blonde
LEAD-6 Study Group
(P2860) (Q51897454)
(Q42506332)
(Q40663660)
(Q36964866)
(Q40585257)
(Q46344895)
(Q33854032)
(Q34598940)
(Q37235840)
(Q45124469)
(Q46458868)
(Q46458866)
(Q51473976)
(Q28293505)
(Q28277510)
(Q51483637)
(Q24656600)
(Q36774902)
(Q38363214)
(Q44909449)
other details
description scientific article

External Links